Clinical Trial Update: A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis [NA]

View source ↗

Summary

A completed double-blind trial assessing whether intraduodenal indomethacin reduces the incidence of post-ERCP pancreatitis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Yale University | Conditions: Pancreatitis | NA | Status: COMPLETED | Results posted: 2017-01-18